This educational webinar will give an overview of how ALL is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international hematology conferences.
What is new and what does this mean for patients?
We will be joined by:
Dr Tobias Menne Consultant Haematologist, Clinical Director for Research, Honorary Senior Lecturer Newcastle University (UK)
Anne - Pierre Pickaert Patient Advocate, Acute Leukaemia Advocates Network (France)
This webinar may be useful for people affected by a diagnosis of ALL: patients, family members, supporters and advocates.